Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Michael Faulx, MD, FACC, is a staff cardiologist in the Section of Clinical Cardiology within the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at the Sydell and Arnold Miller Family Heart & Vascular Institute and Associate Program Director for Cleveland Clinic's Internal Medicine Residency Program. He also serves as an instructor at the Cleveland Clinic Lerner College of Medicine, where he is in the process of becoming an assistant professor of medicine.
Dr. Faulx is board-certified in internal medicine, adult cardiovascular disease and comprehensive adult echocardiography. Dr. Faulx evaluates and treats a broad spectrum of heart and vascular diseases and performs several diagnostic procedures including cardiac catheterization and echocardiography.
Following an undergraduate degree in biochemistry from The Pennsylvania State University, Dr. Faulx received his medical degree from Temple University School of Medicine in Philadelphia. He did his residency in Internal Medicine at Case Medical Center, University Hospitals where he served as Chief Medical Resident. He stayed on at Case for another four years as a Clinical and Research Fellow in Adult Cardiovascular Disease before his appointment to Cleveland Clinic in 2005.
Dr. Faulx has a keen interest in medical education and clinical research. He has authored several review articles and book chapters on a variety of core cardiovascular medicine topics and he continues to remain active in clinical research, primarily exploring the relationship between obstructive sleep apnea and heart disease.
He has authored or co-authored numerous articles and abstracts in leading medical journals including the Journal of the American College of Cardiology, American Heart Journal, Sleep, Circulation Research and the American Journal of Respiratory and Critical Care Medicine. He also serves as an ad hoc reviewer for the journals Sleep and the Cleveland Clinic Journal of Medicine. Dr. Faulx is a fellow of the American College of Cardiology.
General cardiology, critical care cardiology, structural heart disease, ischemic heart disease, pulmonary hypertension, sleep apnea and cardiovascular disease
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Faulx's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.